162 related articles for article (PubMed ID: 16797348)
1. Late humoral rejection in a cardiac transplant recipient treated with the anti-CD20 monoclonal antibody rituximab.
Keren A; Hayes HM; O'Driscoll G
Transplant Proc; 2006 Jun; 38(5):1520-2. PubMed ID: 16797348
[TBL] [Abstract][Full Text] [Related]
2. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
[TBL] [Abstract][Full Text] [Related]
3. Treatment of vascular rejection with rituximab in cardiac transplantation.
Garrett HE; Duvall-Seaman D; Helsley B; Groshart K
J Heart Lung Transplant; 2005 Sep; 24(9):1337-42. PubMed ID: 16143254
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
[TBL] [Abstract][Full Text] [Related]
5. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
6. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
7. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
[TBL] [Abstract][Full Text] [Related]
9. The changing pattern of humoral rejection in cardiac transplant recipients.
Almuti K; Haythe J; Dwyer E; Itescu S; Burke E; Green P; Marboe C; Mancini D
Transplantation; 2007 Aug; 84(4):498-503. PubMed ID: 17713434
[TBL] [Abstract][Full Text] [Related]
10. [Corticoid-resistant rejection and humoral rejection. The diagnostic criteria and therapeutic management].
Crespo Leiro MG; Portela Torrón F; Vázquez González N; Vázquez Rodríguez JM; Yebra Pimentel MT; González Cuesta M
Rev Esp Cardiol; 1995; 48 Suppl 7():77-85. PubMed ID: 8775821
[TBL] [Abstract][Full Text] [Related]
11. B cell monitoring of transplant patients treated with anti-CD20.
Abdallah KO; Prak ET
Clin Transpl; 2006; ():427-37. PubMed ID: 18365400
[TBL] [Abstract][Full Text] [Related]
12. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report.
Aranda JM; Scornik JC; Normann SJ; Lottenberg R; Schofield RS; Pauly DF; Miles M; Hill JA; Sleasman JW; Skoda-Smith S
Transplantation; 2002 Mar; 73(6):907-10. PubMed ID: 11923690
[TBL] [Abstract][Full Text] [Related]
14. Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies.
Cherry R; Nielsen H; Reed E; Reemtsma K; Suciu-Foca N; Marboe CC
J Heart Lung Transplant; 1992; 11(1 Pt 1):24-9; discussion 30. PubMed ID: 1540608
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
16. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
[TBL] [Abstract][Full Text] [Related]
17. Low-dose rituximab therapy for antibody-mediated rejection in a highly sensitized heart-transplant recipient.
Aggarwal A; Pyle J; Hamilton J; Bhat G
Tex Heart Inst J; 2012; 39(6):901-5. PubMed ID: 23304051
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
Allen KJ; Wolverton SE
J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359
[TBL] [Abstract][Full Text] [Related]
19. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
20. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
